Zheng D, Upton R N, Martinez A M, Grant C, Ludbrook G L
Department of Anaesthesia and Intensive Care, Royal Adelaide Hospital, University of Adelaide, North Terrace, SA, Australia.
Anesth Analg. 1998 May;86(5):1109-15. doi: 10.1097/00000539-199805000-00039.
The influence of the bolus injection rate of propofol on its cardiovascular effects has not been extensively studied. We therefore examined the influence of the injection rate of i.v. bolus doses of propofol on its acute cardiovascular effects and peak blood concentrations in seven chronically instrumented sheep. Each received i.v. propofol (200 mg) over 2 min (slow injection) and 0.5 min (rapid injection) on separate occasions in random order. The rapid injection was associated with more profound decreases in mean arterial blood pressure than slow injection (35.7% vs 23.7% maximal reductions from baseline, respectively; P = 0.02). There were no significant differences between the injection rates for peak reductions in myocardial contractility, increases in heart rate, or degree of respiratory depression. Concurrently, the rapid injections were associated with significantly higher arterial (26.9 vs 11.9 mg/L) propofol concentrations in a manner consistent with indicator dilution principles. There were no differences in the peak coronary sinus concentrations between the injection rates. We conclude that the rapid injection of propofol in the context of the induction of anesthesia produced significantly higher peak arterial propofol concentrations and suggest that it is these higher concentrations that produced relatively greater reductions in arterial blood pressure from rapid injections.
Propofol is injected into a vein to initiate anesthesia. It can cause a rapid decrease in blood pressure, which may be dangerous to the patient. We examined the effect of rapid and slow injection rates of propofol in sheep and found that rapid injection caused a greater decrease in blood pressure. This was because rapid injection caused higher concentrations of propofol in the blood immediately after the injection. We believe that if the same processes occur in humans, there may be little advantage in injecting propofol rapidly.
丙泊酚推注速率对其心血管效应的影响尚未得到广泛研究。因此,我们在七只长期植入仪器的绵羊中,研究了静脉推注丙泊酚的速率对其急性心血管效应和血药峰值浓度的影响。每只绵羊分别在不同时间以随机顺序接受静脉注射丙泊酚(200毫克),注射时间分别为2分钟(缓慢注射)和0.5分钟(快速注射)。与缓慢注射相比,快速注射导致平均动脉血压下降更显著(分别从基线最大下降35.7%和23.7%;P = 0.02)。在心肌收缩力峰值降低、心率增加或呼吸抑制程度方面,注射速率之间没有显著差异。同时,快速注射与显著更高的动脉丙泊酚浓度相关(26.9对11.9毫克/升),这与指示剂稀释原理一致。注射速率之间的冠状窦峰值浓度没有差异。我们得出结论,在麻醉诱导过程中快速注射丙泊酚会产生显著更高的动脉丙泊酚峰值浓度,并表明正是这些更高的浓度导致快速注射时动脉血压相对更大幅度的下降。
丙泊酚通过静脉注射来开始麻醉。它可导致血压迅速下降,这对患者可能是危险的。我们研究了丙泊酚快速和缓慢注射速率对绵羊的影响,发现快速注射导致血压下降幅度更大。这是因为快速注射在注射后立即导致血液中丙泊酚浓度更高。我们认为,如果在人类中发生相同的过程,快速注射丙泊酚可能没有什么优势。